Accepted Articles
Editorial
Scaling-up HCV treatment to achieve WHO targets by 2030
Graham Cooke
Scaling-up HCV treatment to achieve WHO targets by 2030
Graham Cooke
Accepted manuscript online: 10 January 2017
Abstract
WHO recently launched a new strategy for tackling viral hepatitis with ambitious goals for reducing both deaths and new infections by 2030 [1]. Antiviral therapy is one only part of a multi-faceted strategy needed to tackle viral hepatitis, but for hepatitis C (HCV), the absence of an effective vaccine means that achieving these targets is going to require substantial scale-up of HCV treatment. Reaching the target of treating 80% of those in need by 2030 will require reaching at least 70 million people [2].....
Continue reading....
Article Of Interest
HCV Universal Treatment Access /Global Elimination - Targeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination? - Editorial
Continue reading....
Article Of Interest
HCV Universal Treatment Access /Global Elimination - Targeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination? - Editorial
No comments:
Post a Comment